HomeTARA • NASDAQ
add
Protara Therapeutics Inc
Previous close
$3.05
Day range
$2.83 - $3.23
Year range
$1.04 - $5.24
Market cap
33.44M USD
Avg Volume
449.89K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 11.04M | 10.50% |
Net income | -10.22M | 73.77% |
Net profit margin | — | — |
Earnings per share | -0.90 | -7.32% |
EBITDA | -10.93M | -10.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 65.58M | -22.27% |
Total assets | 78.95M | -30.31% |
Total liabilities | 10.63M | -5.12% |
Total equity | 68.32M | — |
Shares outstanding | 11.43M | — |
Price to book | 0.51 | — |
Return on assets | -32.97% | — |
Return on capital | -35.29% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -10.22M | 73.77% |
Cash from operations | -8.70M | -73.10% |
Cash from investing | 14.52M | 179.14% |
Cash from financing | 0.00 | — |
Net change in cash | 5.82M | 124.89% |
Free cash flow | -5.33M | -146.90% |
About
Founded
2006
Website
Employees
27